Stock Quote
No news stories for this company within the last 30 days.
CGRB.O
More News
| Press Releases
| Key Developments
Profile
Cougar Biotechnology, Inc. is a development-stage biopharmaceutical company that acquires and develops products for the treatment of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer, and... Full Description
Company Address
Cougar Biotechnology, Inc.
10990 Wilshire Blvd
Suite 1200
Los Angeles CA 90024
P: +1310.9438040
F: +1310.9438059
10990 Wilshire Blvd
Suite 1200
Los Angeles CA 90024
P: +1310.9438040
F: +1310.9438059
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Abbott Laboratories | $54.08 | -0.33 |
| AstraZeneca plc | £2,727.00 | -6.00 |
| Sanofi-Aventis SA | €50.79 | -0.41 |
| CGRB.O | Industry | |
|---|---|---|
| P/E(TTM) | -- | 13.11 |
| P/S(TTM) | -- | 32.32 |
| ROI(TTM) | -81.15 | 2.21 |
| ROE(TTM) | -81.20 | 3.47 |
| Consensus Recommendation | |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -4.39 |
| Total Revenue | $0.00M |
| Net Income | $-23.32M |
| EPS | $-1.12 |
